Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs Curex

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade B+ · #15

Curex

One flat price for either molecule, an oral route for the needle-averse, and a LegitScript-verified nationwide footprint.

Visit Curex

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 87/100 (grade A vs B+). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Curex still earns its place — people who want the tirzepatide upgrade without paying a premium over semaglutide.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results86
97Price honesty88
96Prescriber access89
88Formulary choice86
95Cancellation fairness86
93Member support86

Price, coverage & features

MetricCoreAge RxCurex
Verdict Score94/10087/100
GradeAB+
Semaglutide$149/mo$199/mo
Tirzepatide$349/mo$199/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoYes

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Curex

What we like

  • Identical, transparent pricing on both molecules
  • Offers an oral/sublingual route and covers all 50 states
  • LegitScript-certified

The caveats

  • No brand-name option
  • Flat $199 undercut by cheaper semaglutide-only tiers
  • FDA issued a warning letter to Curex in September 2025; it is public in FDA's warning-letter database

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

People who want the tirzepatide upgrade without paying a premium over semaglutide.

Visit Curex Read the full Curex review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Curex does the reverse.

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.